25.12.2012 Views

revised final - Agency for Toxic Substances and Disease Registry ...

revised final - Agency for Toxic Substances and Disease Registry ...

revised final - Agency for Toxic Substances and Disease Registry ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MERCURY 270<br />

2. HEALTH EFFECTS<br />

Rowens et al. 1991), but glomerular changes have also been reported (Kazantzis et al. 1962; Tubbs et al.<br />

1982).<br />

Although the primary effect of mercury on the kidneys appears to be a direct toxic effect on the renal tubules,<br />

there is also evidence that implicates an immune mechanism of action <strong>for</strong> mercury-induced glomerular<br />

toxicity in some persons. In support of this theory, a few human case studies have reported deposition of IgG,<br />

immune complexes, <strong>and</strong>/or complement C3 along the glomerular basement membrane (Lindqvist et al. 1974;<br />

Tubbs et al. 1982).<br />

Studies in animals support the conclusion that the primary toxic effect of both inorganic <strong>and</strong> organic mercury<br />

in the kidneys is on the epithelial cells of the renal proximal tubules. The changes observed in these studies<br />

were comparable with those observed in humans (i.e., proteinuria, oliguria, increases in urinary excretion of<br />

tubular enzymes, proteinaceous casts, decreased ability to concentrate the urine, decreased<br />

phenolsulfonphthalein excretion, increased plasma creatinine) (Bernard et al. 1992; Chan et al. 1992; Dieter et<br />

al. 1992; Girardi <strong>and</strong> Elias 1991; Jonker et al. 1993a; Kirschbaum et al. 1980; Nielsen et al. 1991; NTP 1993;<br />

Yasutake et al. 1991b). In addition, the animal studies provided detailed in<strong>for</strong>mation regarding the<br />

histopathological changes occurring in the kidneys (Carmignani et al. 1989, 1992; Chan et al. 1992; Dieter et<br />

al. 1992; Falk et al. 1974; Fitzhugh et al. 1950; Fowler 1972; Goering et al. 1992; Hirano et al. 1986; Jonker<br />

et al. 1993a; Klein et al. 1973; Magos <strong>and</strong> Butler 1972; Magos et al. 1985; Mitsumori et al. 1990; Nielsen et<br />

al. 1991; NTP 1993; Yasutake et al. 1991b). The progression of renal toxicity included initial degenerative<br />

changes in the epithelial cells of the proximal tubules (nuclear swelling, increased eosinophilia/basophilia,<br />

vacuolization, <strong>and</strong> cellular hypertrophy). In the early stages, these degenerative changes were accompanied<br />

by tubular regeneration. Occasionally, when there is minor toxic damage, only the regenerative changes were<br />

observed. As the lesions progressed, tubular dilation, desquamation of the epithelial cells, <strong>and</strong> thickening of<br />

the tubular basement membrane were observed. Fibrosis, inflammation, necrosis, <strong>and</strong> atrophy of the tubules<br />

<strong>and</strong> glomerular changes (i.e., hypercellularity, thickening of the glomerular basement membrane) were then<br />

observed.<br />

Several investigators have suggested that the renal toxicity exhibited after administration of organic <strong>for</strong>ms of<br />

mercury (e.g., methylmercury) may actually result from the in vivo metabolism of this <strong>for</strong>m to inorganic<br />

mercury (Fowler 1972; Klein et al. 1973; Magos et al. 1985). This hypothesis is supported by the increase in<br />

the smooth endoplasmic reticulum, a potential site <strong>for</strong> this metabolic conversion, <strong>and</strong> the measurement of

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!